ICUI — ICU Medical, Inc. Stock Price, Chart & AI Report

Neutral Aug 8, 2025 • 01:15 UTC The Motley Fool • Jesterai

ICU Medical (ICUI) Q2 EPS Jumps 40%

ICU Medical reported Q2 2025 earnings with a significant EPS beat of $2.10, exceeding analyst expectations by 40%. Despite strong profitability, the company faces challenges from regulatory issues, tariffs, and segment performance variability, leading to cautious FY2025 guidance.

ICUI medical devices infusion therapy earnings FDA regulations tariffs

Sentiment note

Mixed performance with strong EPS and margin improvements, offset by regulatory challenges, tariff risks, and segment weakness in Vital Care. Cautious management guidance indicates potential near-term uncertainties.

Neutral May 30, 2025 • 08:55 UTC GlobeNewswire Inc. • Researchandmarkets.Com

$3.94 Bn IV Hydration Therapy Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The global IV hydration therapy market is expected to grow from $2.51 billion in 2024 to $3.94 billion by 2030, driven by the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals. Technological advancements and personalized solutions are also boosting consumer demand for home-based, individualized care.

PFE BAX ICUI IV hydration therapy chronic illnesses surgical volumes intravenous drugs home-based care

Sentiment note

The article mentions ICU Medical, Inc. as one of the key market players in the IV hydration therapy market, but does not provide any additional information about the company's performance or outlook.

Negative May 15, 2025 • 01:00 UTC GlobeNewswire Inc. • N/A

Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Organon, Aldeyra, Landstar, and ICU Medical due to issues related to financial results, regulatory matters, and accounting fraud.

OGN ALDX LSTR ICUI Organon Aldeyra Landstar ICU Medical

Sentiment note

ICU Medical received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products, which the FDA stated can significantly impact the functionality and safety of the devices.

Positive Mar 5, 2025 • 16:00 UTC GlobeNewswire Inc. • Future Market Insights, Inc.

Blood Pressure Monitor Market Growth USD 4.36 Billion by 2035 at a 6.1% of CAGR | Future Market Insights, Inc.

The global blood pressure monitor market is projected to grow from USD 2.40 billion in 2025 to USD 4.36 billion by 2035, driven by aging populations, home healthcare, and AI-powered wearables. The rising prevalence of hypertension and technological advancements are key factors driving the market growth.

PHG EW ICUI MMSI blood pressure monitor hypertension home healthcare wearables

Sentiment note

The article includes ICU Medical, Inc. as one of the key players in the blood pressure monitor market, suggesting their strong position and potential for growth.

Positive Mar 4, 2025 • 18:00 UTC GlobeNewswire Inc. • Delveinsight

Global Operating Room Equipment Market is Predicted to Cross ~USD 40 Billion by 2032 | DelveInsight

The operating room equipment market is experiencing strong growth, driven by the increasing volume of surgical procedures and the growing incidence of chronic diseases, particularly among the aging population. North America is expected to dominate the market, with technological advancements and investments in research and development by key players fueling the demand for cutting-edge operating room equipment.

PHG MDT SYK JNJ operating room equipment surgical procedures chronic diseases aging population

Sentiment note

ICU Medical, Inc. is listed as a notable operating room equipment company, suggesting their strong market position and potential for growth.

Positive Feb 18, 2025 • 04:51 UTC GlobeNewswire Inc. • Allied Market Research

Patient Temperature Management Market to Reach $6.5 Billion, Globally, by 2035 at 6.3% CAGR: Allied Market Research

The patient temperature management market is expected to grow from $3.1 billion in 2023 to $6.5 billion by 2035, driven by an increase in surgical procedures, government initiatives, and technological advancements. However, the high cost of devices is a restraint.

MDT BDX MMM SYK patient temperature management surgical procedures government initiatives technological advancements

Sentiment note

ICU Medical, Inc. is listed as a leading player in the patient temperature management market, suggesting its significant role and potential to benefit from the market growth.

Positive Jan 24, 2025 • 10:00 UTC GlobeNewswire Inc. • The Insight Partners

Infusion Devices Market to Reach US$ 23.08 Billion by 2031, Driven by Rising Prevalence of Infectious Diseases

The global infusion devices market is expected to grow significantly due to the increasing prevalence of cancer and strategic initiatives by market players, reaching $23.08 billion by 2031.

BDX BAX ICUI MDT infusion devices cancer strategic initiatives market growth

Sentiment note

The article lists ICU Medical Inc as one of the major companies operating in the infusion devices market, indicating their involvement and potential growth in this sector.

Neutral Dec 16, 2024 • 11:00 UTC GlobeNewswire Inc. • Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.)

The Global Medical Cannula Market Is Poised for Significant Growth USD 447.0 Million by 2034 at a 6.9% of CAGR, driven by Rising Demand for Medical Procedures and Advanced Healthcare Solutions | FMI

The global medical cannula market is expected to grow significantly, reaching $447 million by 2034, driven by increasing healthcare access, technological advancements, and an aging population. The demand for minimally invasive and patient-friendly cannula devices is set to rise, driving innovation in the market.

TFX RMD ICUI medical cannula healthcare medical devices minimally invasive procedures aging population

Sentiment note

The article lists ICU Medical, Inc. as one of the key players in the medical cannula industry, but does not offer any additional details about the company.

Neutral Dec 10, 2024 • 07:45 UTC GlobeNewswire Inc. • Polaris Market Research

Closed System Transfer Device Market Size Poised to Hit USD 4,753.71 million by 2034, Driven by a 14.1% CAGR | PMR

The global closed system transfer device market is projected to grow from $1.1 billion in 2024 to $4.8 billion by 2034, driven by advancements in technology and increasing cancer cases worldwide.

BAX CRMD ICUI closed system transfer device healthcare cancer chemotherapy occupational safety

Sentiment note

The article mentions ICU Medical as one of the key players in the closed system transfer device market, but does not provide any specific information about the company's performance or outlook.

Positive Nov 19, 2024 • 10:41 UTC Benzinga • Globe Newswire

Intravenous Solutions Market to Surpass USD 23.96 Billion by 2031 | SkyQuest Technology

The global intravenous solutions market is projected to grow at a CAGR of 8.0% from 2024 to 2031, driven by the increasing elderly population, rising rates of chronic diseases, and advancements in medical technology.

PFE BAX ICUI GRFS intravenous solutions healthcare medical technology chronic diseases

Sentiment note

The article identifies ICU Medical, Inc. as a key player in the intravenous solutions market, indicating the company's prominence and ability to benefit from the market's growth.

Positive Oct 17, 2024 • 16:31 UTC GlobeNewswire Inc. • Transparency Market Research Inc.

Closed System Transfer Devices (CSTD) Market Size Set to Expand with a 10.0% CAGR, Reaching USD 3.6 Billion by 2034| Analysis by Transparency Market Research Inc.

The global closed system transfer devices (CSTD) market is expected to grow at a CAGR of 10.0% from 2024 to 2034, reaching $3.6 billion. This growth is driven by increasing awareness and education about the risks associated with hazardous medications and the need for safe handling.

ICUI BAX closed system transfer devices CSTD healthcare patient safety hazardous medications

Sentiment note

The article mentions ICU Medical as one of the key players in the CSTD market, indicating their strong presence and potential to benefit from the market growth.

Positive Aug 14, 2024 • 13:46 UTC GlobeNewswire Inc. • Globe Newswire

Home Infusion Therapy Market Forecast and Company Analysis Report 2024-2032

The global home infusion therapy market is expected to grow from $42.7 billion in 2023 to $72.84 billion by 2032, driven by factors like the aging population, technological advancements, and rising healthcare costs. The Asia Pacific region is expected to see significant growth in this market.

PFE SNN JNJ BDX home infusion therapy infusion pumps intravenous therapy healthcare costs

Sentiment note

ICU Medical is mentioned as one of the key players in the home infusion therapy market, indicating its involvement and potential to benefit from the market growth.